New cancer clinical trial: A Phase 1 Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Published on: January 29, 2019 at 12:00PM
Condition:   HER2-expressing Cancers
Intervention:   Drug: ZW49
Sponsor:   Zymeworks Inc.
Recruiting
http://bit.ly/2t3l3a5